-75%

est. 2Y upside i

HealthcareSeries C

NexHealth streamlines healthcare practice operations by connecting every step of the patient journey—from scheduling to payments—directly with health record systems.

Rank

#4220

Sector

Health Tech / SaaS

Est. Liquidity

~3Y

Data Quality

Data: Medium

$1B stale valuation, no revenue disclosure, and 4-year funding gap.

Last updated: March 22, 2026

Bull (15%)+80%

EHR Synchronizer becomes de facto integration layer; $150M+ ARR; strategic acquisition $450-600M.

Base (55%)-30%

Dental growth but specialty struggle; exit $600-750M below Series C; preferences first.

Bear (30%)-65%

Epic expands patient engagement; Weave/Phreesia price compete; down round $300-400M.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

18%

$177M on $1B (17.7%).

Dilution Risk

moderate

May need to raise if not breakeven.

Secondary Liquidity

none

No secondary activity.

Other — 42 roles

View all 42 open roles at NexHealth →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on NexHealth's data — designed to show you've done your homework.

  • 1

    “Current ARR and growth rate?”

  • 2

    “How does NexHealth defend vs Phreesia at 10x revenue?”

  • 3

    “Liquidity path and timeline?”

Community

Valuation Sentiment

Our model estimates -75% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.